Serum 5-S-cysteinyl-dopa levels as a predictive marker for the efficacy of nivolumab in advanced malignant melanoma.

Hiroshi UmemuraTatsuya KajiKota TachibanaShin MorizaneOsamu Yamasaki

Published in: The International journal of biological markers (2019)

Serum 5-S-CD levels have the potential to be an excellent predictive marker for the efficacy of nivolumab therapy in patients with advanced malignant melanoma.

Keyphrases

stem cells
risk assessment
climate change
smoking cessation